255 related articles for article (PubMed ID: 12035294)
1. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
[TBL] [Abstract][Full Text] [Related]
2. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
Indian J Lepr; 2000; 72(4):437-42. PubMed ID: 11212477
[TBL] [Abstract][Full Text] [Related]
3. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
[TBL] [Abstract][Full Text] [Related]
4. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Singh HB; Katoch K; Natrajan M; Sharma RK; Gupta UD; Sharma VD; Singh D; Chauhan DS; Srivastava K; Katoch VM
Acta Leprol; 1999; 11(4):179-82. PubMed ID: 10987049
[TBL] [Abstract][Full Text] [Related]
6. Detection of viable organisms in leprosy patients treated with multidrug therapy.
Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
Acta Leprol; 1999; 11(3):89-92. PubMed ID: 10544720
[TBL] [Abstract][Full Text] [Related]
7. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
[TBL] [Abstract][Full Text] [Related]
8. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
[TBL] [Abstract][Full Text] [Related]
9. Comparison of radiorespirometric Budemeyer assay with ATP assay and mouse foot pad test in detecting viable Mycobacterium leprae from clinical samples.
Agrawal VP; Shetty VP
Indian J Med Microbiol; 2007 Oct; 25(4):358-63. PubMed ID: 18087085
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
11. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
12. Persister studies in leprosy patients after multi-drug treatment.
Gupta UD; Katoch K; Singh HB; Natrajan M; Katoch VM
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
[TBL] [Abstract][Full Text] [Related]
13. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
16. Minocycline in lepromatous leprosy.
Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
[TBL] [Abstract][Full Text] [Related]
17. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
18. Isolation of mycobacterium leprae from untreated borderline tuberculoid, mid-borderline and indeterminate cases using the mouse foot pad technique--a study of 209 cases.
Wakade AV; Shetty VP
Lepr Rev; 2006 Dec; 77(4):366-70. PubMed ID: 17343223
[TBL] [Abstract][Full Text] [Related]
19. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
20. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.
Katoch VM; Katoch K; Ramanathan U; Sharma VD; Shivannavar CT; Datta AK; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]